Day One Biopharmaceutical... (DAWN)

DAWN trades at $7.95, 6.0% above the near-term max pain of $7.5 expiring Oct 17, 2025 (12 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($1-$10), signaling increased put positioning or downside protection. Key magnetic zone at 8 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for DAWN shows a downward trend from 10 to 1, indicating bearish sentiment or hedging activity. The 138% spread signals divergent expectations across timeframes. Most levels below 7.95 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.